HNRNPC and breast carcinoma: By analyzing data from the TCGA and GTEx repositories, we assessed the transcriptome sequencing profiles of HNRNPC across multiple cancer types, offering insights into its Pan-cancer expression profiling indicated a notable overexpression of HNRNPC in 20 out of 26 prevalent malignancies including breast cancer (BRCA), Liver hepatocellular carcinoma (LIHC), and lung adenocarcinoma (LUAD) (Fig. 1A).